Sharekhan

Haleos Labs Ltd

Fri 20/02/2026,15:48:9 NSE: HALEOSLABS

₹ 1300.00 11.90 (0.92%)
BUY NOW Buy Haleos Labs Ltd Stock

Open Free Demat and Trading account in 15 minutes

Home Stock Haleos Labs Ltd

Tue 17/02/2026,16:1:0

Haleos Labs Ltd

Fri 20/02/2026,15:48:9 | NSE : HALEOSLABS

₹ 1300.0011.90 (0.92%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 1260.10

Previous Close

₹ 1288.10

Volume

512

Mkt Cap ( Rs. Cr)

₹393.03

High

₹ 1300.00

Low

₹ 1260.10

52 Week High

₹ 1680.00

52 Week Low

₹ 959.80

Book Value Per Share

₹ 682.76

Dividend Yield

0.11

Face Value

₹ 10.00

What’s Your Call?

Collective community sentiment on Haleos Labs Ltd

Your Vote -

Buy

38.64%

Hold

11.36%

Sell

50.00%

38.64%

44 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

NaN%

Sell Order Quantity

NaN%

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Option Chain

Analyzes market sentiment, predicts Haleos Labs Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Haleos Labs - Copy of Newspaper Publication

    13 Feb 2026, 11:17AM HALEOS LABS LIMITED has informed the Exchange about Copy of Newspaper Publication

  • Haleos Labs Q3 net profit down 13.16% at Rs 5.41 cr

    11 Feb 2026, 7:20PM The company reported standalone net profit of Rs 5.41 crore for the quarter ended December 31, 2025 as compared to Rs 6.23 crore in the same period la

  • Haleos Labs - Outcome of Board Meeting

    11 Feb 2026, 7:06PM HALEOS LABS LIMITED has submitted to the Exchange, the financial results for the period ended December 31, 2025.

  • Haleos Labs - Board Meeting Outcome for Meeting Held On February 11, 2026

    11 Feb 2026, 7:01PM Enclosed - Outcome of 96th Board meeting.

  • Haleos Labs - Board Meeting Intimation for 96Th Board Meeting (11.02.2026)

    4 Feb 2026, 6:20PM Haleos Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2026 ,inter alia, to consider and appr

  • Haleos Labs - Updates

    21 Jan 2026, 1:34PM HALEOS LABS LIMITED has informed the Exchange regarding 'Collaboration (HRV Global)'.

  • Haleos Labs - Collaboration (HRV Global)

    21 Jan 2026, 1:29PM Company has entered into Stategic Development collabration with HRV Global Life Sciences Private Limited and will make further disclosure as and when

  • Haleos Labs - Updates

    13 Jan 2026, 4:49PM HALEOS LABS LIMITED has informed the Exchange regarding 'Report (Special Window)' from December 1, 2025 to January 6, 2026.

  • Haleos Labs - Report (Special Window)

    13 Jan 2026, 4:46PM Enclosed summary from December 1, 2025 to January 6, 2026.

  • Haleos Labs has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2025

    9 Jan 2026, 2:30PM As of December 2025, 71.79% is owned by Indian Promoters and 28.20% by Public. <p align=justify> Top five Promoters holding highest number of shares o

  • Haleos Labs - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    7 Jan 2026, 5:22PM HALEOS LABS LIMITED has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

  • Haleos Labs - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    7 Jan 2026, 5:13PM Enclosed - RTA certificate.

  • Haleos Labs - Trading Window

    20 Dec 2025, 2:05PM HALEOS LABS LIMITED has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

  • Haleos Labs - Updates

    8 Dec 2025, 6:02PM HALEOS LABS LIMITED has informed the Exchange regarding 'Report (Special Window)'.

  • Haleos Labs - Report (Special Window)

    8 Dec 2025, 5:52PM Enclosed is summary for the month of November, 2025

  • Haleos Labs - Disclosure of material issue

    6 Dec 2025, 7:04PM HALEOS LABS LIMITED has informed regarding Disclosure of material issue

  • Haleos Labs - Demand Notice

    6 Dec 2025, 6:57PM Enclosed.

  • Haleos Labs - Updates

    26 Nov 2025, 6:49PM HALEOS LABS LIMITED has informed the Exchange regarding 'New Logo'.

  • Haleos Labs - Name Change

    26 Nov 2025, 6:47PM HALEOS LABS LIMITED has informed the Exchange about new Scrip id of the Company pursuant to change in name of the Company.

  • Haleos Labs - New Logo

    25 Nov 2025, 6:22PM New logo pursuant to change in the name of the Company.

  • Haleos Labs - New Scrip ID (HALEOSLABS)

    25 Nov 2025, 5:50PM New Scrip id of the Company pursuant to change in name of the Company.

  • SMS Pharma receives non-exclusive license to manufacture & supply Molnupiravir

    20 Jan 2022 , 3:43PM Molnupiravir is the first oral, direct-acting antivral shown to be highly effective at reducing infectious virus
Load More
Show Less

Key fundamentals

Evaluate the intrinsic value of Haleos Labs Ltd stock 

Name March-25 March-24 March-23 March-22 March-21
Assets 276.348 264.957 249.1726 210.9553 168.1632
Liabilities 276.348 264.957 249.1726 210.9553 168.1632
Equity 3.0233 3.0233 3.0233 3.0233 3.0233
Gross Profit 44.2317 34.4313 26.4065 31.3647 29.7351
Net Profit 21.3708 13.0654 13.2176 25.3813 13.1683
Cash From Operating Activities 28.0325 14.7514 4.5753 -14.6554 21.6184
NPM(%) 6.41 4.35 4.19 7.34 5.05
Revenue 333.371 300.0016 315.2418 345.6281 260.2555
Expenses 289.1393 265.5703 288.8353 314.2634 230.5204
ROE(%) 10.35 6.32 6.4 12.29 6.37

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day
1.5 15 0.12 1373.4
23 Sep 2024 1.5 15 0.12 696.3
22 Sep 2022 1.5 15 0.12 637.6
20 Sep 2021 1.5 15 0.12 659.8
19 Sep 2019 1.5 15 0.12 483.4

Peers

Other companies within the same industry or sector that are comparable to Haleos Labs Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 725.70 0.24 43.09 770.44 301.39 0.69
Lotus Eye Hospital and Institute Ltd 117.51 -5.00 379.06 2807.40 3.55 0.00
Vaishali Pharma Ltd 7.73 -0.64 0.00 17611.73 3.13 0.00
Astec Lifesciences Ltd 633.05 -0.99 0.00 2647.44 -604.77 0.00

Company Info

SMS Lifesciences India Limited incorporated under the provisions of the Companies Act, 1956, on 31st day of May, 2006, originally as Private Limited Company in the name of "Potluri Real Estate Private Limited" and subsequently changed its name to "Potluri Packaging Industries Private Limited" on 6th November, 2013. Thereafter the Company had changed its name as "SMS Lifesciences India Private Limited" on 4th August, 2014 and subsequently converted as Public Limited Company with effect from 22nd June, 2016 and its Corporate Identity No. is U74930TG2006PLC050223. The Company is presently engaged in the business of manufacturing, buying, selling, offering consultancy, importing and exporting, acting as commission agents and generally dealing with of all types of Organic & Inorganic Chemicals, Pharmaceuticals, Active Pharmaceutical Ingredients (API) and Intermediates. 2020 -Company has received the prestigious award in the 5th edition of India Pharma and Medical Device 2020.

SMS Lifesciences India Limited incorporated under the provisions of the Companies Act, 1956, on 31st day of May, 2006, originally as Private Limited Company in the name of "Potluri Real Estate Private Limited" and subsequently changed its name to "Potluri Packaging Industries Private Limited" on 6th November, 2013. Thereafter the Company had changed its name as "SMS Lifesciences India Private Limited" on 4th August, 2014 and subsequently converted as Public Limited Company with effect from 22nd June, 2016 and its Corporate Identity No. is U74930TG2006PLC050223. The Company is presently engaged in the business of manufacturing, buying, selling, offering consultancy, importing and exporting, acting as commission agents and generally dealing with of all types of Organic & Inorganic Chemicals, Pharmaceuticals, Active Pharmaceutical Ingredients (API) and Intermediates. 2020 -Company has received the prestigious award in the 5th edition of India Pharma and Medical Device 2020.

Read More

Parent Organisation

Haleos Labs Ltd.

Founded

31/05/2006

Managing Director

Mr.TVVSN Murthy

NSE Symbol

HALEOSLABSBE

FAQ

The current price of Haleos Labs Ltd is ₹ 1300.00.

The 52-week high for Haleos Labs Ltd is ₹ 1300.00 and the 52-week low is ₹ 1260.10.

The market capitalization of Haleos Labs Ltd is currently ₹ 393.03. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Haleos Labs Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Haleos Labs Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Haleos Labs Ltd shares.

The CEO of Haleos Labs Ltd is Mr.TVVSN Murthy, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT